...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

Wondering how would the ongoing OTC trading affect a Zenith IPO?

Koo

Share
New Message
Please login to post a reply